Palisade Bio, Inc. (Ticker: PALI) has recently exhibited remarkable volatility, which is prominently reflected in the technical charts. On the date in focus, the stock closed at $6.79, witnessing an impressive surge of +37.73% as seen in the first screenshot and +34.89% in the second screenshot. Such a price action invites a multi-dimensional analysis to decipher...
wall of worry can also sometimes be wall of profit. if this trend continues we should see $9 soon, and if it breaks were probably losing 50%
This is my bearish trend idea. However wait for a fall back to a key level after trend continue to downtrend momentum, because overall structure breakout and continue to downtrend. You can see it high time frame momentum. Good luck
Palisade Bio, Inc. (PALI) plans to initiate a phase 3 study for accelerating the return of bowel function in the first half of 2022 and for the first patient to be enrolled in the second half of 2022. On 2/2/2022 LADENBURG THALM/SH SH brokerage Initiated Coverage for PALI with a Buy rating and $5.00 Price Target. Market Cap 12.841Mil 52 Week Range 0.76 -...